Yes, oxycodone and acetaminophen are frequently taken together and are formulated together in combination medications like Percocet and Tylox. However, this combination carries a significant hepatotoxicity risk if acetaminophen doses exceed recommended limits, and both drugs require careful dose management in patients with liver disease, heavy alcohol use, or concurrent hepatotoxic medications. The FDA has issued multiple warnings about acetaminophen overdose as a leading cause of acute liver failure, and when combined with an opioid that may itself impair judgment or cause sedation, the risk of accidental overdose increases substantially.
The FDA does not classify oxycodone and acetaminophen as a contraindicated pair in absolute terms. In fact, combination products containing both drugs have FDA approval for moderate-to-moderately severe pain. However, the FDA has issued critical warnings about acetaminophen's hepatotoxic potential across multiple product labels since 2009, and these warnings apply with particular force when acetaminophen is combined with opioids.
According to the FDA's 2011 guidance on acetaminophen-containing products, the maximum single dose should not exceed 1,000 mg, and total daily intake should not exceed 3,000–4,000 mg depending on individual risk factors. For combination products like oxycodone/acetaminophen (Percocet), the typical formulation contains 5 mg oxycodone with 325 mg acetaminophen per tablet. The FDA label for Percocet explicitly warns that acetaminophen can cause severe hepatotoxicity at doses above recommended limits, particularly in patients with underlying liver disease, in those who consume alcohol regularly, or in those taking other acetaminophen-containing products simultaneously.
The American Association of Poison Control Centers (AAPCC) has documented thousands of cases of unintentional acetaminophen overdose, with the FDA receiving over 1,000 reports of acute liver failure associated with acetaminophen exposure in a single year. Many of these cases involved patients who did not realize they were taking multiple acetaminophen-containing products, or who took oxycodone/acetaminophen combination pills at doses higher than prescribed.
While oxycodone and acetaminophen do not compete for the same receptor or metabolic pathway in a direct pharmacokinetic sense, they interact at multiple clinically important levels.
Acetaminophen Metabolism and Hepatotoxicity: Acetaminophen is metabolized primarily by the liver via phase II conjugation reactions (sulfation and glucuronidation). A small fraction (5–15%) is oxidized by the cytochrome P450 enzyme CYP2E1 to N-acetyl-p-benzoquinone imine (NAPQI), a highly reactive intermediate. Under normal circumstances, this reactive metabolite is rapidly detoxified by glutathione. However, when acetaminophen is taken at supratherapeutic doses, or when glutathione stores are depleted (by alcohol use, fasting, or other metabolic stress), NAPQI accumulates and binds to hepatocyte proteins, causing cell death and hepatic necrosis.
Oxycodone's Effect on Judgment and Overdose Risk: Oxycodone is a mu-opioid receptor agonist that crosses the blood–brain barrier and produces dose-dependent central nervous system depression, analgesia, sedation, and euphoria. At high doses or in opioid-naive patients, oxycodone causes impaired cognition and judgment. This sedation and cognitive impairment may cause a patient to lose track of how many doses they have taken, leading to accidental overdose on the acetaminophen component. A patient who takes three or four Percocet tablets in quick succession (perhaps not realizing they already took a dose an hour earlier) may inadvertently ingest 975–1,300 mg of acetaminophen in a short window, followed by repeated doses throughout the day, resulting in chronic supratherapeutic exposure.
Delayed Symptom Recognition: Oxycodone-induced sedation and euphoria may mask early symptoms of acetaminophen hepatotoxicity, such as nausea, vomiting, and malaise. A patient who is drowsy from oxycodone may not recognize abdominal pain or jaundice as warning signs until significant liver damage has occurred.
Alcohol and Drug Interactions: Patients taking oxycodone for pain relief often self-medicate with alcohol to enhance sedation or manage breakthrough pain, or they may already drink regularly. Chronic alcohol use induces CYP2E1 expression, shunting more acetaminophen toward the toxic NAPQI pathway. The combination of oxycodone (which increases overdose risk through cognitive impairment), alcohol (which increases acetaminophen's toxicity), and acetaminophen itself creates a particularly hazardous triad.
Certain patient populations face substantially higher risk from this combination:
A 58-year-old man with no significant medical history underwent knee arthroscopy and was prescribed oxycodone/acetaminophen 5/325 mg tablets, one every 4–6 hours for pain. The discharge instructions stated a maximum of 8 tablets daily. However, the patient experienced significant breakthrough pain on postoperative day 2 and took two tablets every 3–4 hours without consulting his surgeon, believing that "more pain medication would help him heal faster." Over a 24-hour period, he consumed 10 tablets, totaling 3,250 mg of acetaminophen. By postoperative day 5, he developed nausea, right upper quadrant abdominal pain, and mild jaundice. Laboratory testing revealed an aspartate aminotransferase (AST) level of 1,200 IU/L and alanine aminotransferase (ALT) of 1,450 IU/L — consistent with acute drug-induced hepatotoxicity. He required hospitalization for monitoring and N-acetylcysteine therapy, the antidote for acetaminophen overdose. This patient's risk was compounded by inadequate pain management counseling and lack of patient understanding about maximum daily acetaminophen limits.
A 72-year-old woman with osteoarthritis was prescribed oxycodone/acetaminophen 5/325 mg, one tablet twice daily for baseline pain. She also took a daily multivitamin containing acetaminophen, used over-the-counter Tylenol Cold & Flu tablets during a respiratory infection (two doses of 1,000 mg each), and drank two to three glasses of wine most evenings. Over the course of three weeks, her cumulative acetaminophen exposure reached approximately 4,500–5,000 mg daily. She presented to her primary care physician with fatigue, jaundice, and elevated liver enzymes (AST 890, ALT 1,100). Her daughter noted that her mother had been confused and irritable for several days — a sign of hepatic encephalopathy. The patient required hospitalization and was treated with supportive care and N-acetylcysteine. She recovered with complete resolution of liver function tests over 6 weeks, but the episode prompted a complete medication review and a switch to non-acetaminophen-based pain management (an NSAID or an opioid monoproduct).
If You Are Currently Taking Oxycodone/Acetaminophen Combination:
If You Are Prescribed Oxycodone with Acetaminophen for the First Time:
For Healthcare Providers:
Seek immediate medical attention if you experience any of the following while taking oxycodone/acetaminophen:
Call your pharmacist or doctor immediately if you believe you have taken more than the prescribed dose, or if you have taken acetaminophen from multiple sources on the same day.
For more information on opioid and acetaminophen interactions with other medications, see our guides on oxycodone and alcohol interaction, acetaminophen and warfarin interaction, and oxycodone and benzodiazepine interaction.
Your medication regimen may include multiple drugs that interact in ways not immediately apparent from single-pair analysis. To verify that your complete list of medications is safe to take together, visit checkdruginteractions.com and enter all your current drugs, supplements, and over-the-counter products. Our comprehensive database, powered by over 250,000 FDA drug labels, will highlight any clinically significant interactions and provide evidence-based guidance. When in doubt, always consult with your pharmacist or physician before starting, stopping, or changing any medication.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
Methotrexate and ibuprofen have a major FDA-documented interaction. Learn mechanism, monitoring, and safe management strategies for healt...
Tacrolimus and fluconazole interaction explained. Learn severity, risks, and what FDA labels say about combining these drugs.
Is it safe to take methimazole and warfarin together? Learn about this drug interaction from FDA data and pharmacology.